Nektar Therapeutics
0 sources
Financials
0001193125-26-104547Nektar Therapeutics
Summary
Nektar Therapeutics is a business[1]. It ranks in the top 4% of business entities by monthly Wikipedia readership (55 views/month).[2]
Key Facts
- Nektar Therapeutics is in the country of United States[3].
- Nektar Therapeutics is in the country of US[4].
- Nektar Therapeutics's instance of is recorded as business[5].
- Nektar Therapeutics's instance of is recorded as public company[6].
- Nektar Therapeutics's headquarters location is recorded as San Francisco[7].
- Nektar Therapeutics's stock exchange is recorded as Nasdaq[8].
- 1990 marks the founding of Nektar Therapeutics[9].
- Nektar Therapeutics's official website is recorded as http://www.nektar.com/[10].
- Nektar Therapeutics's product or material produced is recorded as Inhalable insulin[11].
- Nektar Therapeutics's legal form is recorded as 8888[12].
Product Details
The following facts are restated verbatim from public-domain and CC0 open-data sources — every line is independently verifiable against the named source's catalog.
GLEIF Golden Copy — Level 1 entity data
-
Legal Entity Identifier (LEI): 5299005I24806IOIYE03[13]
-
Registered legal name: Nektar Therapeutics[14]
-
Legal jurisdiction: US-DE[15]
-
GLEIF entity category: GENERAL[16]
-
Legal form (ISO 20275 ELF): 8888[17]
-
Other legal form: Corporation[18]
-
Entity status: ACTIVE[19]
-
LEI registration status: LAPSED[20]
-
LEI first registered: 2018-10-10[21]
-
LEI last updated: 2021-07-14[22]
-
LEI next renewal: 2019-10-10[23]
-
Managing LOU: 5299000J2N45DDNE4Y28[24]
-
Registration authority: RA000602[25]
-
Authority entity ID: 2903970[26]
-
Conformity flag: NON_CONFORMING[27]
Body
Founding
1990 marks the founding of Nektar Therapeutics[9].
Operations
Nektar Therapeutics's headquarters location is recorded as San Francisco[7].
Ownership
Nektar Therapeutics's stock exchange is recorded as Nasdaq[8]. Its product or material produced is recorded as Inhalable insulin[11].
Why It Matters
Nektar Therapeutics ranks in the top 4% of business entities by monthly Wikipedia readership (55 views/month).[2]